We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Machine Learning Tool Enables Noninvasive Diagnosis and Monitoring of Colorectal Cancer

By LabMedica International staff writers
Posted on 23 May 2025

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States when considering both genders. More...

Colonoscopy remains the gold standard for CRC diagnosis, but it is invasive, costly, and necessitates extensive bowel preparation and sedation. Recent progress in high-throughput “omics” technologies presents an opportunity for less invasive CRC diagnostic methods through the identification of biomarkers. To further enhance cancer diagnostics, researchers have now developed a machine learning-based tool capable of detecting molecular profile differences related to metabolism between patients with colorectal cancer and healthy individuals.

In a study involving biological samples from over 1,000 participants, scientists at The Ohio State University (Columbus, OH, USA) identified metabolic changes linked to disease severity and genetic mutations that elevate the risk of colorectal cancer. While additional analysis is ongoing, the resulting "biomarker discovery pipeline" holds promise as a noninvasive method for diagnosing colorectal cancer and monitoring disease progression. However, the tool is not intended to replace colonoscopy as the primary screening method for cancer, and more studies involving additional samples are needed before the pipeline can be considered for clinical application.

The research, published in the journal iMetaOmics, also demonstrates an advancement in machine learning techniques, combining two established methods to create the new platform: partial least squares-discriminant analysis (PLS-DA) for broad molecular profile differentiation, and an artificial neural network (ANN) that identifies molecules enhancing the platform's predictive capability. The researchers named the resulting biomarker pipeline PANDA, which stands for PLS-ANN-DA. For the study, the team analyzed two sets of biological data derived from blood samples: metabolites, which are products of biochemical reactions that break down food to produce energy and perform other essential functions, and transcripts, RNA readouts of DNA instructions predicting related protein changes.

Reliance on biomarkers for diagnostics across different populations can be challenging due to the wide array of conditions that affect molecular profiles in living systems. Nevertheless, this study highlights several molecular changes that show potential—though not certainty—in evaluating the presence and progression of colorectal cancer in a nationally representative group of patients. Metabolism pathways related to purines, compounds essential for DNA formation and degradation, stood out in the analysis, showing higher overall activity in cancer patients compared to healthy controls, and lower activity in those with more advanced tumor stages. The research team plans to continue analyzing metabolites associated with various biological signals to further refine the PANDA biomarker pipeline.

“We believe this is a good tool for disease diagnostics and monitoring, especially because metabolic-based biomarker analysis could also be utilized to monitor treatment effectiveness,” said Jiangjiang Zhu, co-senior author of the study and an associate professor of human sciences at The Ohio State University. “When a patient is taking drug A versus drug B, especially for cancer, time is essential. If they don’t have a good response, we want to know that as soon as possible so we can change the treatment regimen. If metabolites can help indicate a treatment’s effectiveness faster than traditional methods like pathology or protein markers, we hope they could be good indicators for doctors who are caring for patients.”


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The VeraBIND Tau assay is a novel blood test that identifies the presence of active tau pathology (Photo courtesy of 123RF)

First Blood-Based Test Measures Key Alzheimer's Biomarker in Asymptomatic and Symptomatic Individuals

Alzheimer’s disease (AD), the sixth leading cause of death in the United States, affects an estimated 7.2 million Americans aged 65 or older. Current diagnostic methods for AD are often invasive, expensive,... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.